79
total announcements
540025.BO · 15 min delayed
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has announced the availability of the audio recording of its conference call held on November 03, 2026, to discuss the unaudited financial results for the quarter and half year ended September 30, 2026.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has submitted an application to the stock exchanges for reclassification of 13 promoter group members from 'Promoter Group' to 'Public' category, as per Regulation 31A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has published its unaudited consolidated financial results for the quarter and six months ended September 30, 2026, as per the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has announced the closure of its buyback program, where it repurchased 2,410,906 equity shares from the open market.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has announced its Q2 FY27 earnings, with revenue growing 16% YoY to ₹ 2,145 million, EBITDA growing 20% YoY to ₹ 721 million, and PAT increasing to ₹ 512 million. The company has also reported a 12% QoQ growth in revenue and a 36% QoQ growth in EBITDA.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has announced its unaudited financial results for the second quarter and half year ended September 2026, with revenue growing 16% y-o-y and 12% q-o-q to ₹2,145 million, and profit after tax growing 14% y-o-y to ₹512 million.
Advanced Enzyme Technologies Ltd
The Board of Directors of Advanced Enzyme Technologies Ltd has approved the unaudited financial results for the quarter and half year ended September 30, 2026, and analyzed the requests from the promoter group members for their reclassification from promoter group category to public category shareholders.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, which were approved by the Board of Directors. The company has also analyzed requests from promoter group members for reclassification from promoter group category to public category shareholders.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, which were approved by the Board of Directors on October 31, 2026. The company has also analyzed requests from promoter group members for reclassification from promoter group category to public category shareholders.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has closed its buyback program, purchasing 2,410,906 shares at an average price of ₹ 289.09 per share, utilizing ₹ 696,962,962.22, which is 99.99% of the maximum buyback size.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has submitted a daily report under Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 30, 2026. The company has bought back 24,10,906 Equity Shares from the open market through stock exchanges mechanism.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has submitted a daily report under Regulation 18(i) of the Buyback Regulations regarding the equity shares bought back on October 29, 2026. The company bought 54,455 equity shares through the stock exchange mechanism.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has submitted a daily report under Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 28, 2026, with 64,583 shares bought back through Emkay Global Financial Services Limited.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has submitted a daily report under Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 27, 2026.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd will host a conference call on November 3, 2026, to discuss its un-audited financial results for the quarter and half year ended September 30, 2026.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has submitted a daily report under Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 26, 2026.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has submitted a daily report under Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 23, 2026.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has scheduled a Board Meeting on October 31, 2026, to consider and approve the Un-Audited Standalone And Consolidated Financial Results for the Quarter and Half Year ended September 30, 2026. The trading window will remain closed until November 2, 2026.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has submitted a daily report under Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 22, 2026, with 58,326 shares bought from Emkay Global Financial Services Limited at ₹263.3605 per share.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd has submitted a daily report under Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 21, 2026, through the stock exchanges mechanism.